Hydrea 500 mg Capsules – Hydroxyurea Oral Antineoplastic & Sickle Cell Therapy

EGP2,160

Field Value
Name Hydrea 500 mg Capsules
Brand Bristol-Myers Squibb
Strength 500 mg
Quantity 100 Capsules (or as per packaging)
Form Hard Capsules
Expiry Date Varies by batch (e.g., 12/2026) — to be confirmed on packaging
Outer Appearance Green-pink capsules in blister or bottle form
Country of Origin USA (or EU/India depending on market source)
Product Code HYD500-BMS (example; actual SKU/product code depends on supplier)

Hydrea 500 mg is an oral hydroxyurea capsule used in various blood disorders and cancers. It reduces painful sickle cell crises, slows leukemia progression, and supports radiation therapy for head and neck cancers. Safe use requires close blood monitoring.

In stock

Description

1. Introduction to Hydrea 500 mg Capsules

Hydrea (hydroxyurea) is a locked prescription medication taken orally. It works by inhibiting DNA synthesis via ribonucleotide reductase blockade, slowing the proliferation of blood and cancer cells. Hydrea is an FDA-approved generic and essential medicine used widely since 1967.

2. Therapeutic Uses

  • Chronic Myelogenous Leukemia (CML): Hydrea helps reduce leukemic cell counts .

  • Sickle Cell Disease (SCD): Boosts fetal hemoglobin production, reducing painful vaso‑occlusive crises and transfusion needs in children and adults.

  • Head & Neck Cancer: Often combined with radiation for squamous cell carcinomas.

  • Other Myeloproliferative Disorders: Used in essential thrombocythemia, polycythemia vera, and occasionally psoriasis (Wikipedia).

  • Melanoma research: Emerging data suggests potential in certain melanomas via miRNA modulation .

3. Mechanism of Action

Hydrea inhibits ribonucleotide reductase, arresting cell cycle in G1/S phase and enhancing radiosensitivity. In SCD, it elevates fetal hemoglobin (HbF) to reduce sickling.

4. Dosage & Administration

  • Starting dose for adults with normal renal function: approx. 15 mg/kg once daily.

  • Renal impairment (CrCl <60 mL/min): dose reduced by 50% (≈ 7.5 mg/kg).

  • Pediatric care: Customized to body weight; tablets/capsules taken whole, with/without food .

Explore more: Natrol Acidophilus Probiotic 1 Billion (150 ct) – Digestive & Immune Support Supplement

5. Monitoring & Safety Precautions

  • Bone marrow suppression: Frequent CBCs before and during treatment to monitor WBCs, platelets, RBCs.

  • Infection risk: Watch for fevers, chills, sore throat .

  • Secondary malignancies: Rare skin cancer or leukemia risk with long-term use .

  • Pregnancy & fertility: Teratogenic; contraception recommended for 6 months post‑therapy in both genders.

  • Vaccinations: Avoid live vaccines while on therapy .

  • Sun protection: Use sunscreen; avoid excessive sun exposure.

6. Common & Serious Side Effects

Side Effect Type Examples
Common Low blood counts, nausea, loss of appetite, headache, constipation, mouth sores
Serious Fever/infections, bleeding/bruising, black/tarry stools, dyspnea, skin ulcers or gangrene

If serious symptoms appear, stop Hydrea and seek medical attention immediately.

Explore more: Horbaach Vitamin D3 5000 IU + K2 MK-7 100 mcg | High Potency 180 Softgels

7. Handling & Storage

  • Handle with care; avoid contact if pregnant or via caregivers (use gloves).

  • Store at 15–30 °C, tightly sealed in original packaging, out of children’s reach.

8. Drug Interactions & Contraindications

  • Contraindicated: severe bone marrow depression, prior hypersensitivity, severe anemia, during pregnancy.

  • Interactions: other myelosuppressive agents or recent radiation increase marrow toxicity risk; adjust dose accordingly.

9. Why Choose Hydrea?

  • Well‑studied with 50+ years of use.

  • Generic & essential medicine – high cost‑effectiveness.

  • Versatile indications include sickle cell, CML, head/neck cancers, etc.


✅ FAQs

Q1: How long does it take for Hydrea to reduce sickle‑cell crises?
A: Most patients observe fewer painful crises and transfusion needs within 2–4 months of consistent dosing.

Q2: Can Hydrea be used during pregnancy?
A: No—Hydrea is teratogenic. Effective contraception is required during treatment and for 6 months after therapy ends.

Q3: What types of blood monitoring are needed?
A: Complete blood counts (CBC) are done weekly during initiation, then monthly once stabilized to watch for cytopenias .

Q4: Can Hydrea cause hair loss or skin ulcers?
A: Yes. Hair thinning, nail discoloration, and rare skin ulcers/gangrene have been reported—contact your physician if skin lesions occur.

Q5: Could Hydrea increase the risk of other cancers?
A: Long-term use in myeloproliferative disorders has a small risk of secondary leukemia or skin cancer—regular skin checks are advised.

Explore more at No style Like : Cancer treatment drugs


User Reviews

  • ⭐⭐⭐⭐⭐ Very effective for SCD “After starting Hydrea, my child hasn’t had a pain crisis in over four months—life‑changing!”

  • ⭐⭐⭐⭐ Good for leukemia but tough monitoring “It helps control my CML, but I do worry about frequent blood tests.”

  • ⭐☆☆☆☆ Caused mouth ulcers “I developed painful mouth sores and had to pause treatment.”

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Hydrea 500 mg Capsules – Hydroxyurea Oral Antineoplastic & Sickle Cell Therapy”